23andMe, Inc.
https://www.23andme.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From 23andMe, Inc.
Digital Health Start-Ups Continue To Be Attractive SPAC Targets
According to Rock Health, 52 health-care focused SPACs are looking for targets. This comes as blank check companies are facing rising scrutiny by regulators.
Theator Raises $15.5M To Bring AI-Based Surgical Platform To US Academic Medical Centers
Theator plans to expand its AI-powered surgical technology platform beyond general surgery and gain a foothold in the US.
Virgin Group Fund Elevates 23AndMe $3.5Bn IPO
23andMe is teaming up with blank check company VG Acquisition Corp to go public, making the move into personalized health care.
23AndMe To Go Public At $3.5Bn With Sir Richard Branson-Backed SPAC
23andMe is teaming up with blank check company VG Acquisition Corp to go public, making the move into personalized health care.
Company Information
- Industry
- Laboratory Testing Services
- Services
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
-
Diagnostic Imaging Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Saliva-based Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics